2004
DOI: 10.1016/s0377-1237(04)80018-2
|View full text |Cite
|
Sign up to set email alerts
|

Treatment of Acute Mountain Sickness and High Altitude Pulmonary Oedema

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2009
2009
2023
2023

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(4 citation statements)
references
References 13 publications
0
4
0
Order By: Relevance
“…High altitude sickness is a growing concern due to the increased number of travelers, sportspersons, adventurers, pilgrims, army personnel, and even non‐resident locals living at high altitude >2,500 m (Kapoor, Narula, & Anand, 2004; Paralikar & Paralikar, 2010). Mild to life‐threatening clinical conditions such as acute mountain sickness (AMS), high altitude pulmonary edema (HAPE), high altitude cerebral edema (HACE), and High‐altitude pulmonary hypertension (HAPH), have been reported (Kapoor et al, 2004) at high altitude. The physiological effects of high altitude begin at 1,500–3,500 m (m) and gradually increase at 3,500–5,500 m and become severe at extremely high altitude (above 5,500 m) (Paralikar & Paralikar, 2010).…”
Section: Introductionmentioning
confidence: 99%
“…High altitude sickness is a growing concern due to the increased number of travelers, sportspersons, adventurers, pilgrims, army personnel, and even non‐resident locals living at high altitude >2,500 m (Kapoor, Narula, & Anand, 2004; Paralikar & Paralikar, 2010). Mild to life‐threatening clinical conditions such as acute mountain sickness (AMS), high altitude pulmonary edema (HAPE), high altitude cerebral edema (HACE), and High‐altitude pulmonary hypertension (HAPH), have been reported (Kapoor et al, 2004) at high altitude. The physiological effects of high altitude begin at 1,500–3,500 m (m) and gradually increase at 3,500–5,500 m and become severe at extremely high altitude (above 5,500 m) (Paralikar & Paralikar, 2010).…”
Section: Introductionmentioning
confidence: 99%
“…The incidence of high altitude pulmonary oedema is related to the rate of ascent, the altitude reached, individual susceptibility and exertion, while cold increases pulmonary arterial pressure by means of sympathetic stimulation, which is an additional risk factor [1]. The annual incidence of hospital admission for HAPO in our Armed Forces is as low as 0.15 per thousand soldiers per year [2].…”
Section: Medical Problemsmentioning
confidence: 99%
“…Although, till date the pathogenesis of beverages to combat various high-altitude sicknesses this disease is poorly understood thus drug development process has been overlooked as well. Kapoor et al (2004) reported use of some drugs for the treatment of a few categories of HAS, mainly acute mountain sickness (AMS) and high-altitude pulmonary edema. To the best of our knowledge, natural products were rarely used for the docking of proteins cumulatively associated to HAS (Liang et al, 2018;Yeerjiang et al, 2023) and with traditional foods or beverages, this study is one of a kind.…”
Section: Introductionmentioning
confidence: 99%